Cardinal Health Company Profile (NYSE:CAH)

About Cardinal Health (NYSE:CAH)

Cardinal Health logoCardinal Health, Inc. is a healthcare services and products company. The Company operates through two segments: Pharmaceutical and Medical. The Pharmaceutical segment distributes branded and generic pharmaceutical, specialty pharmaceutical, over-the-counter healthcare and consumer products. This segment also operates nuclear pharmacies and cyclotron facilities; provides pharmacy management services to hospitals, as well as medication therapy management and patient outcomes services to hospitals, other healthcare providers and payers, and provides services to healthcare companies. The Medical segment distributes a range of medical, surgical and laboratory products, and provides services to hospitals, ambulatory surgery centers, clinical laboratories and other healthcare providers. This segment also manufactures, sources and develops its own Cardinal Health brand medical and surgical products. It provides post-acute care management and transition services, and software to hospitals.

Industry, Sector and Symbol:
  • Sector: Medical
  • Industry: Drug Retailers
  • Sub-Industry: Health Care Distributors
  • Symbol: NYSE:CAH
  • CUSIP: 14149Y10
  • Web:
  • Market Cap: $20.93 billion
  • Outstanding Shares: 316,453,000
Average Prices:
  • 50 Day Moving Avg: $67.09
  • 200 Day Moving Avg: $72.38
  • 52 Week Range: $62.70 - $84.88
  • Trailing P/E Ratio: 16.41
  • Foreward P/E Ratio: 11.96
  • P/E Growth: 2.07
Sales & Book Value:
  • Annual Revenue: $129.98 billion
  • Price / Sales: 0.16
  • Book Value: $21.54 per share
  • Price / Book: 3.07
  • Annual Dividend: $1.85
  • Dividend Yield: 2.8%
  • EBITDA: $3.07 billion
  • Net Margins: 0.99%
  • Return on Equity: 26.20%
  • Return on Assets: 4.81%
  • Debt-to-Equity Ratio: 1.33%
  • Current Ratio: 1.34%
  • Quick Ratio: 0.80%
  • Average Volume: 2.22 million shs.
  • Beta: 0.86
  • Short Ratio: 4.82

Frequently Asked Questions for Cardinal Health (NYSE:CAH)

What is Cardinal Health's stock symbol?

Cardinal Health trades on the New York Stock Exchange (NYSE) under the ticker symbol "CAH."

How often does Cardinal Health pay dividends? What is the dividend yield for Cardinal Health?

Cardinal Health announced a quarterly dividend on Wednesday, August 9th. Stockholders of record on Monday, October 2nd will be paid a dividend of $0.4624 per share on Sunday, October 15th. This represents a $1.85 dividend on an annualized basis and a dividend yield of 2.80%. The ex-dividend date is Friday, September 29th. View Cardinal Health's Dividend History.

How were Cardinal Health's earnings last quarter?

Cardinal Health, Inc. (NYSE:CAH) posted its quarterly earnings data on Wednesday, August, 2nd. The company reported $1.31 EPS for the quarter, topping the Zacks' consensus estimate of $1.24 by $0.07. The firm had revenue of $32.97 billion for the quarter, compared to the consensus estimate of $32.73 billion. Cardinal Health had a net margin of 0.99% and a return on equity of 26.20%. The business's revenue was up 5.0% on a year-over-year basis. During the same period last year, the company earned $1.14 earnings per share. View Cardinal Health's Earnings History.

When will Cardinal Health make its next earnings announcement?

Cardinal Health is scheduled to release their next quarterly earnings announcement on Monday, November, 6th 2017. View Earnings Estimates for Cardinal Health.

What guidance has Cardinal Health issued on next quarter's earnings?

Cardinal Health updated its FY18 earnings guidance on Wednesday, August, 2nd. The company provided earnings per share (EPS) guidance of $5.60 for the period, compared to the Thomson Reuters consensus EPS estimate of $5.25. Cardinal Health also updated its FY17 guidance to $4.85-5.10 EPS.

Where is Cardinal Health's stock going? Where will Cardinal Health's stock price be in 2017?

12 analysts have issued twelve-month price objectives for Cardinal Health's shares. Their predictions range from $72.00 to $82.00. On average, they expect Cardinal Health's share price to reach $76.44 in the next twelve months. View Analyst Ratings for Cardinal Health.

Who are some of Cardinal Health's key competitors?

Who are Cardinal Health's key executives?

Cardinal Health's management team includes the folowing people:

  • George S. Barrett, Chairman of the Board, Chief Executive Officer
  • Michael C. Kaufmann, Chief Financial Officer
  • Donald M. Casey Jr., Chief Executive Officer - Medical Segment
  • Jon L. Giacomin, Chief Executive Officer - Pharmaceutical segment
  • Pamela O. Kimmet, Chief Human Resource Officer
  • Patricia B. Morrison, Executive Vice President - Customer Support Services and Chief Information Officer
  • Michele A. M. Holcomb, Executive Vice President, Strategy and Corporate Development
  • Craig S. Morford, Chief Legal and Compliance Officer
  • Gregory B. Kenny, Lead Independent Director
  • David John Anderson, Independent Director

Who owns Cardinal Health stock?

Cardinal Health's stock is owned by a variety of of institutional and retail investors. Top institutional shareholders include Osborn Williams & Donohoe LLC (0.01%) and Eqis Capital Management Inc. (0.00%). Company insiders that own Cardinal Health stock include Carole S Watkins, Craig S Morford, Donald M Jr Casey, Falk T Stephen, George S Barrett, Jon L Giacomin, Patricia Morrison and Stuart G Laws. View Institutional Ownership Trends for Cardinal Health.

Who sold Cardinal Health stock? Who is selling Cardinal Health stock?

Cardinal Health's stock was sold by a variety of institutional investors in the last quarter, including Eqis Capital Management Inc. and Osborn Williams & Donohoe LLC. Company insiders that have sold Cardinal Health stock in the last year include George S Barrett and Jon L Giacomin. View Insider Buying and Selling for Cardinal Health.

How do I buy Cardinal Health stock?

Shares of Cardinal Health can be purchased through any online brokerage account. Popular online brokerages include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Scottrade, Fidelity and Charles Schwab.

What is Cardinal Health's stock price today?

One share of Cardinal Health stock can currently be purchased for approximately $66.15.

MarketBeat Community Rating for Cardinal Health (NYSE CAH)
Community Ranking:  3.1 out of 5 (star star star)
Outperform Votes:  474 (Vote Outperform)
Underperform Votes:  299 (Vote Underperform)
Total Votes:  773
MarketBeat's community ratings are surveys of what our community members think about Cardinal Health and other stocks. Vote "Outperform" if you believe the stock will outperform the S&P 500 over the long term. Vote "Underperform" if you believe the stock will underperform the S&P 500 over the long term. You may vote once every thirty days.

Analyst Ratings

Consensus Ratings for Cardinal Health (NYSE:CAH) (How are Consensus Ratings Calculated?)
Ratings Breakdown: 8 Hold Ratings, 4 Buy Ratings
Consensus Rating:Hold (Score: 2.33)
Consensus Price Target: $76.44 (15.56% upside)
Consensus Price Target History for Cardinal Health (NYSE:CAH)
Price Target History for Cardinal Health (NYSE:CAH)
Analysts' Ratings History for Cardinal Health (NYSE:CAH)
DateFirmActionRatingPrice TargetImpact on Share PriceDetails
10/12/2017Needham & Company LLCReiterated RatingHoldN/AView Rating Details
10/10/2017Cowen and CompanyUpgradeBuy$74.00N/AView Rating Details
9/19/2017Royal Bank Of CanadaInitiated CoverageSector Perform -> Sector Perform$72.00LowView Rating Details
9/17/2017Robert W. BairdReiterated RatingHold$73.00LowView Rating Details
8/29/2017Jefferies Group LLCSet Price TargetHold$77.00LowView Rating Details
8/3/2017Credit Suisse GroupLower Price TargetOutperform$87.00 -> $81.00MediumView Rating Details
7/4/2017Evercore ISIReiterated RatingOutperformN/AView Rating Details
4/28/2017Tigress FinancialInitiated CoverageNeutral -> NeutralLowView Rating Details
4/22/2017Barclays PLCReiterated RatingOverweight$88.00 -> $82.00LowView Rating Details
4/21/2017Leerink SwannSet Price TargetHold$72.00LowView Rating Details
4/19/2017William BlairDowngradeOutperform -> Market PerformLowView Rating Details
1/3/2017MizuhoDowngradeBuy -> Neutral$79.00N/AView Rating Details
10/10/2016Cleveland ResearchDowngradeBuy -> NeutralN/AView Rating Details
9/19/2016Bank of America CorporationReiterated RatingHold$90.00N/AView Rating Details
9/16/2016Goldman Sachs Group, Inc. (The)DowngradeBuy -> Neutral$90.00 -> $83.00N/AView Rating Details
9/12/2016Morgan StanleyReiterated RatingHold$91.00N/AView Rating Details
8/4/2016Deutsche Bank AGBoost Price TargetHold$83.00 -> $89.00N/AView Rating Details
8/3/2016Citigroup Inc.Boost Price TargetNeutral$87.00 -> $93.00N/AView Rating Details
6/20/2016FBR & CoReiterated RatingBuyN/AView Rating Details
6/1/2016Raymond James Financial, Inc.DowngradeOutperform -> Market PerformN/AView Rating Details
4/18/2016Avondale PartnersInitiated CoverageOutperform$111.00N/AView Rating Details
(Data available from 10/19/2015 forward)


Earnings History for Cardinal Health (NYSE:CAH)
Earnings by Quarter for Cardinal Health (NYSE:CAH)
Earnings History by Quarter for Cardinal Health (NYSE CAH)
DateQuarterConsensus EstimateActual EPSRevenue EstimateActual RevenueRelease LinkConference CallDetails
10/30/2017$1.12N/AView Earnings Details
8/2/2017Q4 2017$1.24$1.31$32.73 billion$32.97 billionViewListenView Earnings Details
5/1/2017Q3 2017$1.46$1.53$32.30 billion$31.82 billionViewListenView Earnings Details
2/7/2017Q217$1.23$1.34$33.63 billion$33.10 billionViewListenView Earnings Details
10/31/2016Q117$1.21$1.24$31.12 billion$32.00 billionViewListenView Earnings Details
8/2/2016Q416$1.13$1.14$31.06 billion$31.40 billionViewN/AView Earnings Details
4/28/2016Q316$1.33$1.43$30.54 billion$30.70 billionViewListenView Earnings Details
2/1/2016Q216$1.26$1.30$29.23 billion$31.40 billionViewN/AView Earnings Details
11/2/2015Q116$1.10$1.38$27.19 billion$28.10 billionViewN/AView Earnings Details
7/30/2015Q415$0.99$1.00$26.05 billion$27.50 billionViewListenView Earnings Details
4/30/2015Q3$1.16$1.19$24.40 billion$25.38 billionViewN/AView Earnings Details
1/29/2015Q215$1.11$1.20$23.43 billion$25.50 billionViewN/AView Earnings Details
10/30/2014Q115$0.96$1.00$22.43 billion$24.07 billionViewN/AView Earnings Details
8/4/2014Q414$0.81$0.83$21.88 billion$2.90 billionViewN/AView Earnings Details
5/1/2014Q314$1.01$1.01$21.72 million$21.40 millionViewN/AView Earnings Details
1/31/2014Q214$0.84$0.79$20.74 billion$22.20 billionViewN/AView Earnings Details
10/31/2013Q114$0.86$1.10$22.73 billion$24.50 billionViewN/AView Earnings Details
8/1/2013Q4 2013$0.77$0.79$24.56 billion$25.40 billionViewN/AView Earnings Details
5/2/2013Q3 2013$0.95$1.20$24.72 billion$24.60 billionViewN/AView Earnings Details
2/5/2013Q2 2013$0.86$0.93$24.61 million$22.75 millionViewN/AView Earnings Details
10/30/2012Q113$0.79$0.81$26.33 million$25.90 millionViewN/AView Earnings Details
8/2/2012$0.73$0.73ViewN/AView Earnings Details
5/3/2012$0.88$0.94ViewN/AView Earnings Details
2/2/2012$0.77$0.81ViewN/AView Earnings Details
10/27/2011$0.72$0.73ViewN/AView Earnings Details
8/4/2011$0.58$0.59ViewN/AView Earnings Details
4/28/2011$0.69$0.75ViewN/AView Earnings Details
2/3/2011$0.61$0.69ViewN/AView Earnings Details
(Data available from 1/1/2011 forward)


Earnings Estimates for Cardinal Health (NYSE:CAH)
2017 EPS Consensus Estimate: $5.28
2018 EPS Consensus Estimate: $5.03
QuarterNumber of EstimatesLow EstimateHigh EstimateAverage Estimate
Q1 20173$1.21$1.26$1.23
Q2 20173$1.20$1.33$1.26
Q3 20173$1.43$1.60$1.50
Q4 20174$1.24$1.41$1.29
Q1 20183$0.99$1.18$1.08
Q2 20183$1.13$1.34$1.23
Q3 20183$1.41$1.55$1.46
Q4 20183$1.20$1.30$1.27
(Data provided by Zacks Investment Research)


Current Dividend Information for Cardinal Health (NYSE:CAH)
Most Recent Dividend:10/15/2017
Annual Dividend:$1.85
Dividend Yield:2.80%
Dividend Growth:13.10% (3 Year Average)
Payout Ratio:45.79% (Trailing 12 Months of Earnings)
37.37% (Based on This Year's Estimates)
33.45% (Based on Next Year's Estimates)
Track Record:12 Years of Consecutive Dividend Growth
Dividend Payments by Quarter for Cardinal Health (NYSE:CAH)

Dividend History by Quarter for Cardinal Health (NYSE CAH)
AnnouncedPeriodAmountYieldEx-Dividend DateRecord DatePayable Date
(Data available from 1/1/2013 forward)

Insider Trades

Insider Trading and Institutional Ownership History for Cardinal Health (NYSE:CAH)
Insider Ownership Percentage: 0.97%
Institutional Ownership Percentage: 87.88%
Insider Trades by Quarter for Cardinal Health (NYSE:CAH)
Institutional Ownership by Quarter for Cardinal Health (NYSE:CAH)
Insider Trades by Quarter for Cardinal Health (NYSE:CAH)
Transaction DateInsider NameTitleBuy/SellNumber of SharesAverage Share PriceTotal TransactionDetails
5/12/2017Jon L GiacominCEO of Cardinal Health's pharmaceutical segmentSell23,270$72.87$1,695,684.90View SEC Filing  
2/10/2017George S BarrettChairmanSell217,994$77.23$16,835,676.62View SEC Filing  
11/10/2016George S BarrettChairmanSell217,995$71.29$15,540,863.55View SEC Filing  
8/18/2016Patricia MorrisonInsiderSell43,959$82.50$3,626,617.50View SEC Filing  
8/18/2016Stuart G LawsSVPSell9,703$82.45$800,012.35View SEC Filing  
8/16/2016Jon L GiacominCEOSell47,251$82.77$3,910,965.27View SEC Filing  
8/11/2016Craig S MorfordInsiderSell12,697$83.13$1,055,501.61View SEC Filing  
8/10/2016Donald M Jr. CaseyCEOSell59,180$83.59$4,946,856.20View SEC Filing  
8/10/2016George S BarrettChairmanSell250,000$83.63$20,907,500.00View SEC Filing  
8/9/2016George S BarrettCEOSell129,818$83.76$10,873,555.68View SEC Filing  
8/8/2016George S BarrettCEOSell20,428$83.75$1,710,845.00View SEC Filing  
5/20/2016Carole S WatkinsInsiderSell84,617$77.33$6,543,432.61View SEC Filing  
11/6/2015Falk T. StephenEVPSell30,085$87.66$2,637,251.10View SEC Filing  
8/20/2015George S. BarrettCEOSell300,000$83.08$24,924,000.00View SEC Filing  
5/12/2015Falk T StephenEVPSell39,428$86.12$3,395,539.36View SEC Filing  
5/11/2015George S BarrettCEOSell300,000$86.44$25,932,000.00View SEC Filing  
3/4/2015Colleen F ArnoldDirectorSell9,801$87.65$859,057.65View SEC Filing  
3/3/2015Richard C NotebaertDirectorSell9,801$88.20$864,448.20View SEC Filing  
2/20/2015Carole S WatkinsInsiderSell33,847$87.00$2,944,689.00View SEC Filing  
2/10/2015Carole S WatkinsInsiderSell50,770$85.00$4,315,450.00View SEC Filing  
2/10/2015George S BarrettCEOSell300,000$84.87$25,461,000.00View SEC Filing  
11/7/2014Mark R BlakeEVPSell24,668$79.50$1,961,106.00View SEC Filing  
9/5/2014Carole S WatkinsInsiderSell40,794$75.00$3,059,550.00View SEC Filing  
9/4/2014Michael C KaufmannCEOSell50,216$74.95$3,763,689.20View SEC Filing  
8/27/2014Jeffrey William HendersonCFOSell26,567$72.63$1,929,561.21View SEC Filing  
8/18/2014Jeffrey William HendersonCFOSell78,637$72.06$5,666,582.22View SEC Filing  
8/18/2014Mark R BlakeEVPSell4,782$72.15$345,021.30View SEC Filing  
8/18/2014Michael C KaufmannCEOSell6,833$72.06$492,385.98View SEC Filing  
8/8/2014Craig S MorfordInsiderSell43,359$70.03$3,036,430.77View SEC Filing  
8/8/2014Jeffrey William HendersonCFOSell118,093$69.72$8,233,443.96View SEC Filing  
7/24/2014Mark R BlakeEVPSell23,114$73.41$1,696,798.74View SEC Filing  
7/24/2014Stuart G LawsCAOSell21,266$72.50$1,541,785.00View SEC Filing  
7/14/2014Jeffrey William HendersonCFOSell23,632$70.65$1,669,600.80View SEC Filing  
5/19/2014Mark BlakeEVPSell4,703$66.50$312,749.50View SEC Filing  
5/13/2014Mark BlakeEVPSell2,822$66.50$187,663.00View SEC Filing  
5/7/2014Jeffrey William HendersonCFOSell27,031$63.83$1,725,388.73View SEC Filing  
2/11/2014Mark BlakeEVPSell2,330$68.53$159,674.90View SEC Filing  
2/11/2014Michael KaufmannCEOSell388,995$67.46$26,241,602.70View SEC Filing  
2/10/2014George BarrettCEOSell200,000$66.64$13,328,000.00View SEC Filing  
2/5/2014Gregory KennyDirectorSell18,175$65.39$1,188,463.25View SEC Filing  
2/4/2014Carole WatkinsInsiderSell46,666$65.71$3,066,422.86View SEC Filing  
2/4/2014Falk StephenEVPSell17,926$65.56$1,175,228.56View SEC Filing  
2/4/2014Richard NotebaertDirectorSell10,727$65.68$704,549.36View SEC Filing  
11/11/2013George BarrettCEOSell200,000$62.71$12,542,000.00View SEC Filing  
9/11/2013Mark R BlakeEVPSell14,584$51.53$751,513.52View SEC Filing  
8/19/2013Mark BlakeEVPSell4,925$51.27$252,504.75View SEC Filing  
8/16/2013Falk StephenEVPSell10,000$51.50$515,000.00View SEC Filing  
8/15/2013Craig MorfordInsiderSell20,000$51.33$1,026,600.00View SEC Filing  
8/13/2013George BarrettCEOSell75,000$52.09$3,906,750.00View SEC Filing  
8/13/2013Jeffrey William HendersonCFOSell54,590$51.99$2,838,134.10View SEC Filing  
8/8/2013Calvin DardenDirectorSell3,254$51.48$167,515.92View SEC Filing  
8/5/2013Mark BlakeEVPSell29,166$51.53$1,502,923.98View SEC Filing  
7/26/2013Jeffrey William HendersonCFOSell76,781$50.99$3,915,063.19View SEC Filing  
7/18/2013Jeffrey William HendersonCFOSell57,623$49.99$2,880,573.77View SEC Filing  
7/15/2013Jeffrey William HendersonCFOSell14,660$49.99$732,853.40View SEC Filing  
7/11/2013Jeffrey William HendersonCFOSell83,211$48.99$4,076,506.89View SEC Filing  
6/19/2013John F FinnDirectorSell11,070$48.51$537,005.70View SEC Filing  
5/28/2013Jean G SpauldingDirectorSell8,350$47.35$395,372.50View SEC Filing  
5/22/2013Richard C NotebaertDirectorSell3,197$48.10$153,775.70View SEC Filing  
5/20/2013Carole S WatkinsInsiderSell4,612$48.00$221,376.00View SEC Filing  
5/20/2013Jean G SpauldingDirectorSell1,666$47.90$79,801.40View SEC Filing  
11/1/2012Stuart G LawsCAOSell2,564$41.22$105,688.08View SEC Filing  
10/4/2012Jeffrey William HendersonCFOSell46,226$40.00$1,849,040.00View SEC Filing  
(Data available from 1/1/2013 forward)


Headline Trends for Cardinal Health (NYSE:CAH)
Latest Headlines for Cardinal Health (NYSE:CAH)
DateHeadline logoSee what the IHS Markit Score report has to say about Cardinal Health Inc. - October 19 at 4:17 AM logoShanghai Pharma bids for U.S. Cardinal Health's China business - October 18 at 6:11 PM logoIndustry Group Rank Analysis Makes Cardinal Health (CAH) a Strong Sell - October 18 at 5:17 PM logoCardinal Health to Webcast Discussion of First-Quarter Results for Fiscal Year 2018 on November 6 - October 17 at 5:41 PM logoCardinal Health, distributors respond to Washington Post/60 Minutes opioid investigation - Columbus Business First - October 16 at 10:46 PM logoCardinal Health, Inc. : CAH-US: Dividend Analysis : October 02nd, 2017 (record date) : By the numbers : October 16, 2017 - October 16 at 5:44 PM logo7 Stocks To Watch Ahead Of The 60 Minutes DEA-Opioid Exposé - October 13 at 5:31 PM logoCardinal Health, Inc. (CAH) Stock Rating Reaffirmed by Needham & Company LLC - October 12 at 12:40 PM logoCardinal Health competitor – and Dublin neighbor – gains clout in acquisition by larger company - October 11 at 6:21 PM logoHow Shanghai Pharma Can Get High - October 9 at 10:38 PM logoYou Should Not Miss Cardinal Health In 2017 - October 9 at 5:37 PM logoCardinal's China Exit Pits PE Against State Firm - October 9 at 5:37 PM logoCardinal Health (CAH) Stock Upgraded to Sell - - October 7 at 3:22 AM logoRobust Growth Expected for Cardinal Health’s Specialty Solutions - October 6 at 5:11 PM logoPatient Recovery Acquisition May Boost Cardinal Health’s Revenues - October 6 at 5:11 PM logoCardinal Health Expected to Report Modest Revenue Growth - October 5 at 8:53 PM logoCardinal Health: Stable Net Profit Margins in Fiscal 2018? - October 5 at 8:53 PM logoAnalyst Recommendations for Cardinal Health and Peers in October - October 5 at 3:51 PM logoCardinal Health, Inc. (CAH) Receives Consensus Recommendation of "Hold" from Analysts - October 4 at 8:44 PM logo$33.41 Billion in Sales Expected for Cardinal Health, Inc. (CAH) This Quarter - October 4 at 9:42 AM logoBig Pharma Is Getting Hit With a Huge Wave of Opioid Suits - October 2 at 3:08 PM logoEx-Dividend Reminder: Cardinal Health, Raymond James Financial and CubeSmart - September 27 at 5:41 PM logoCardinal Health: A Dividend Aristocrat Trading Near Its All-Time High Yield - Seeking Alpha - September 20 at 10:42 PM logoCardinal Health, Inc. (CAH) Research Coverage Started at Royal Bank Of Canada - September 19 at 7:38 AM logoCardinal Health, Inc. (CAH) Stock Rating Reaffirmed by Robert W. Baird - September 17 at 7:42 AM logoHow Safe Is Cardinal Health's Dividend? - September 15 at 5:18 PM logoHow Safe Is Cardinal Health's Dividend? - September 15 at 8:16 AM logo Analysts Anticipate Cardinal Health, Inc. (CAH) Will Announce Quarterly Sales of $33.44 Billion - September 15 at 3:18 AM logo Analysts Anticipate Cardinal Health, Inc. (CAH) Will Announce Earnings of $1.01 Per Share - September 14 at 12:24 AM logoCardinal Health (CAH) and Prestige Brand Holdings (PBH) Critical Analysis - September 11 at 10:32 PM logoNeedham & Company LLC Reaffirms Hold Rating for Cardinal Health, Inc. (CAH) - September 11 at 8:24 PM logoCardinal Health, Inc. (CAH) Receives Average Recommendation of "Hold" from Analysts - September 9 at 4:48 PM logoWhy Is Cardinal Health (CAH) Down 2.7% Since the Last Earnings Report? - Nasdaq - September 9 at 3:21 AM logoWhy Is Cardinal Health (CAH) Down 2.7% Since the Last Earnings Report? - September 8 at 5:16 PM logo4 Top MedTech Stocks for Dividend Investors in 2017 - September 8 at 5:16 PM logoNew Mexico sues opioid drug manufacturers, distributors - September 7 at 4:37 PM logoHead-To-Head Review: Prestige Brand Holdings (PBH) and Cardinal Health (CAH) - September 4 at 2:12 PM logoRecent Buy: Cardinal Health Inc. - August 31 at 4:46 PM logoCardinal Health Becomes Oversold - Nasdaq - August 30 at 6:13 PM logoCardinal Health, Inc. (CAH) Given a $77.00 Price Target by Jefferies Group LLC Analysts - August 29 at 9:28 PM logoBert's Recent Buy - Cardinal Health - August 24 at 4:58 PM logoETFs with exposure to Cardinal Health, Inc. : August 24, 2017 - August 24 at 4:57 PM logoDividend Yield of Cardinal Health - August 23 at 5:04 PM logoCardinal Health: Cramer's Top Takeaways - - August 22 at 10:34 PM logoCardinal Health, Inc. :CAH-US: Earnings Analysis: Q4, 2017 By the Numbers : August 21, 2017 - August 22 at 10:34 PM logoCramer Remix: Why these US oil fields may be about to make a big market impact - August 22 at 10:34 PM logoCramer Remix: Why these US oil fields may be about to mak... - August 22 at 10:34 PM logoCardinal Health: Cramer's Top Takeaways - August 22 at 10:34 PM logoDrug Distributors: Bear Vs. Bull Debate - August 21 at 4:48 PM logoCardinal Health, Inc. : CAH-US: Dividend Analysis : July 03rd, 2017 (record date) : By the numbers : August 16, 2017 - August 16 at 5:24 PM



Cardinal Health (CAH) Chart for Thursday, October, 19, 2017

This page was last updated on 10/19/2017 by Staff

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with's FREE daily email newsletter.